Your session is about to expire
← Back to Search
Radiation Therapy
Radiation Therapy for Brain Metastases
Phase 1 & 2
Waitlist Available
Led By Susan L. McGovern, MD
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month after radiation therapy
Awards & highlights
Study Summary
This trial is testing a new way to give radiation to people who have already had radiation for brainstem glioma, to see if it is safe and effective.
Eligible Conditions
- Brain Metastases
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 month after radiation therapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month after radiation therapy
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Optimal Dose Level Among Three Radiation Therapy (RT) Dose Levels
Trial Design
1Treatment groups
Experimental Treatment
Group I: Radiation TherapyExperimental Treatment1 Intervention
Starting dose of 24 Gray (Gy) in 2 Gy fractions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Radiation Therapy
2017
Completed Phase 3
~7250
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,664 Previous Clinical Trials
40,926,121 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
2,973 Previous Clinical Trials
1,789,309 Total Patients Enrolled
Susan L. McGovern, MDPrincipal InvestigatorM.D. Anderson Cancer Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger